相关实验视频
Updated: Jan 15, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.2K
麻性雷诺现象:一个病例报告
Beatriz Vitó Madureira1, Rita Aranha2, Rita Soares Costa1
1Internal Medicine, Local Health Unit of Entre Douro e Vouga, Santa Maria da Feira, PRT.
Cureus
|January 14, 2026
概括
麻性雷诺病现象可以在癌症患者中表现为一种新的血管的症状. 在患有恶性瘤的成年人中,早期识别对于管理症状和了解血管综合征至关重要.
科学领域:
- 在瘤学瘤学.
- 血管医学 血管医学
- 医学案例报告 病例报告
背景情况:
- 雷诺氏现象是一种血管的疾病,具有主要和次要原因.
- 恶性瘤可以与各种类神经瘤综合征一起出现.
- 肺癌,特别是状细胞癌,可能与不寻常的并发症有关.
研究的目的:
- 报告一个患有肺癌的患者患有副瘤雷诺现象的病例.
- 突出考虑癌症患者新发动的血管缩症状的副瘤病因的重要性.
- 增强对瘤学中的瘤性血管综合征的理解.
主要方法:
- 一个63岁的男性患有第四阶段状细胞癌的病例报告.
- 患者在息性化疗期间出现了远端上肢不对称的短暂变色.
- 不同诊断排除了雷诺现象的其他次要原因.
主要成果:
- 患者的症状被归因于肺癌的副次瘤病因.
- 肢体的不对称和短暂的变色是出现的血管症状.
- 排除其他原因支持癌症与雷诺现象之间的联系.
结论:
- 麻性雷诺病现象是患有已确定的恶性瘤的患者的潜在并发症.
- 在成年人中,新出现的或非典型的血管缩症状需要考虑对瘤综合征的考虑.
- 及时诊断和管理对于患者护理和对癌症相关血管疾病的研究至关重要.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
349
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
349
Disorders of the Autonomic Nervous System
1.4K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Rheumatic Heart Disease IV: Nursing Management
264
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
264
